GlassScriptPhysician profile
Ariel O'Neil
NPI 1073046074
$6,202.64
in general payments reported to CMS, 2019-2025
15 companies · $2,144 in 2025
The $2,144 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $159 · 2024: $3,900 · 2025: $2,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Travel and Lodging: $1,132 · Food and Beverage: $931 · Long Term Medical Supply Or Device Loan: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Travel and Lodging | $1,131.69 |
| Food and Beverage | $930.97 |
| Long Term Medical Supply Or Device Loan | $639.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,971.90 | 2023-2025 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $639.98 | 2024 | Acell |
| Medtronic, INC. | $120.99 | 2024-2025 | Ligasure, Plasmablade(Tm) |
| Innovation Technologies INC | $101.62 | 2025 | Irrisept |
| Conmed Corporation | $71.53 | 2024-2025 | Airseal |
| Smith+Nephew, INC. | $51.29 | 2024-2025 | Collagenase Santyl, Pico |
| Abbvie INC. | $48.57 | 2025 | |
| Endogastric Solutions, INC | $38.41 | 2023 | Esophyx |
| Kerecis Limited | $30.23 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $26.27 | 2024 | Puraply Am |
| Ethicon US, LLC | $22.08 | 2025 | Harmonic, Echelon Circular |
| Alpha Orthopedic Systems | $21.09 | 2024 | |
| Olympus America INC. | $19.93 | 2025 | Olympus |
| Tela Bio, INC. | $19.87 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Solventum Corporation | $18.88 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariel O'Neil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.